Basit öğe kaydını göster

dc.contributor.authorDeligezer, Uğur
dc.contributor.authorDalay, N
dc.contributor.authorYaman, F
dc.contributor.authorErten, N
dc.date.accessioned2021-03-05T22:01:24Z
dc.date.available2021-03-05T22:01:24Z
dc.identifier.citationDeligezer U., Yaman F., Erten N., Dalay N., "Frequent copresence of methylated DNA and fragmented nucleosomal DNA in plasma of lymphoma patients", CLINICA CHIMICA ACTA, cilt.335, ss.89-94, 2003
dc.identifier.issn0009-8981
dc.identifier.otherav_dba60d85-82e7-4cb1-b1d3-b24e2d882636
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/144777
dc.identifier.urihttps://doi.org/10.1016/s0009-8981(03)00279-1
dc.description.abstractBackground: The circulating DNA in plasma/serum of cancer patients has been shown to reflect the characteristics of the tumor DNA including molecular changes, such as rnethylation, point mutations and microsatellite instability. Fragmented nucleosomal DNA in plasma resulting from apoptotic death of the tumor cells may also provide an indication for tumor DNA. In this study, we comparatively analysed plasma DNA methylation and presence of fragmented nucleosomal DNA in patients with lymphoproliferative diseases. Methods: Methylation in the first exon of the tumor supressor gene p16 was investigated by the methylation-sensitive restriction enzyme-related PCR. DNA fragmentation in plasma was analysed by gel electrophoresis. Results: p16 gene methylation was found to occur in 73% of patients but in none of the 20 healthy controls. Nucleosomal DNA fragmentation was detectable in 81% of patients. In 67% of patients, copresence of both parameters was observed. Presence of both parameters a frequent event and may be used as a marker for early diagnosis and during the follow-up of the disease. (C) 2003 Elsevier B.V. All rights reserved.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIBBİ LABORATUVAR TEKNOLOJİSİ
dc.titleFrequent copresence of methylated DNA and fragmented nucleosomal DNA in plasma of lymphoma patients
dc.typeMakale
dc.relation.journalCLINICA CHIMICA ACTA
dc.contributor.department, ,
dc.identifier.volume335
dc.identifier.startpage89
dc.identifier.endpage94
dc.contributor.firstauthorID169379


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster